Change over period: —
NSE · APOLLOHOSP
APOLLO HOSP.
-2.7% from the 52-week high · +29.8% above the low
Apollo Hospitals Enterprise Ltd. engages in the operation and management of hospitals, diagnostic centers and pharmacies. The company is headquartered in Chennai, Tamil Nadu and currently employs 83,147 full-time employees. The firm is engaged in the business of providing hospital services and selling pharma and wellness products through a network of pharmacies, including the operation of multidisciplinary private hospitals, clinics, diagnostic centers and pharmacies. The firm's segments include Healthcare Services, Retail Health and Diagnostics, Digital Health and Pharmacy Distribution, and Others. The company is engaged in hospitals and hospitals-based services. Retail Health and Diagnostics segment includes clinics and diagnostics. Digital Health and Pharmacy Distribution segment is engaged in the business of procurement and distribution of pharmaceuticals, fast moving consumer goods and private label products business from various services using the digital platform. The firm has approximately 10,000 beds across 71 hospitals, 6000 pharmacies and 200 clinics and diagnostic centers, as well as 150 telemedicine centers.
The short version. APOLLO HOSP. reported revenue of ₹7,615 crore for Sep 2026, up 20.8% from a year earlier. Net profit was ₹630 crore (up 32.1% year on year). Return on equity was 20.5% in Mar 2026. Promoter holding was 28.02% in Sep 2026, down 1.31 points over 8 quarters.
1 · The price
How has the stock traded?
APOLLO HOSP. trades 2.7% below its 52-week high and 29.8% above its 52-week low.
2 · The business
Is it growing?
Reported results · ₹ crore
Revenue and profit
Show the numbers
Quarterly
| Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 7615 | 7044 | 6606 | 6477 | 6304 | 5842 | 5592 | 5527 |
| Net profit | 630 | 581 | 529 | 502 | 477 | 433 | 390 | 372 |
| Net margin % | 8.3 | 8.2 | 8.0 | 7.8 | 7.6 | 7.4 | 7.0 | 6.7 |
| EPS (₹) | 43.81 | 40.39 | 36.81 | 34.93 | 33.19 | 30.1 | 27.1 | 25.89 |
Annual
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 25228 | 21794 | 19059 | 16612 | 14663 | 10560 | 11247 | 9617 |
| Net profit | 1942 | 1446 | 899 | 819 | 1056 | 150 | 455 | 236 |
| Net margin % | 7.7 | 6.6 | 4.7 | 4.9 | 7.2 | 1.4 | 4.0 | 2.5 |
| EPS (₹) | 135.04 | 100.56 | 62.5 | 56.97 | 73.42 | 10.46 | 32.7 | 16.97 |
3 · The quality
How well does it turn capital into profit?
Return on equity was 20.5% in Mar 2026; debt to equity is 0.60.
Profitability · 4 years
Returns and margins
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | |
|---|---|---|---|---|
| Return on equity % | 20.5 | 17.6 | 13.0 | 13.2 |
| Return on capital % | 19.5 | 15.3 | 15.0 | 13.7 |
| EBITDA margin % | 15.5 | 14.6 | 13.0 | 12.8 |
| Net margin % | 7.6 | 6.6 | 4.7 | 4.9 |
Compound growth
Revenue vs profit
| 3 years | 5 years | |
|---|---|---|
| Revenue CAGR | 15.0% | 19.1% |
| Profit CAGR | 33.3% | 66.8% |
4 · The owners
Who holds it, and are they adding?
Shareholding pattern (%)
Quarter by quarter
| Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | Change | |
|---|---|---|---|---|---|---|---|---|---|
| Promoter | 29.33 | 29.34 | 29.34 | 28.02 | 28.02 | 28.02 | 28.02 | 28.02 | -1.31 |
| FII | 45.27 | 42.74 | 43.49 | 44.2 | 43.54 | 42.62 | 41.5 | 43.18 | -2.09 |
| DII | 19.98 | 22.29 | 21.34 | 21.12 | 21.51 | 22.76 | 23.72 | 22.07 | +2.09 |
| Public | 5.19 | 5.41 | 5.61 | 6.43 | 6.71 | 6.37 | 6.54 | 6.49 | +1.3 |
Mutual fund holdings · Oct 2026
406 schemes hold this stock
337 the month before.
- Groww BSE Hospitals ETF21.36% of NAV
- Invesco India Pharma and Healthcare Fund9.08% of NAV
- SBI Equity Minimum Variance Fund8.13% of NAV
- Invesco India Business Cycle Fund7.93% of NAV
- DSP Healthcare Fund7.89% of NAV
- Bandhan Healthcare Fund7.67% of NAV
- ADITYA BIRLA SUN LIFE NIFTY HEALTHCARE ETF7.54% of NAV
- DSP Nifty Healthcare Index Fund7.54% of NAV
5 · The model view
What does our factor model say?
Factor scores, model flags and screen results for APOLLO HOSP. are part of the Wright portfolio review.
Run your free portfolio reviewWatchouts
What to review
Model flags are shown inside the portfolio review, alongside your other holdings.
Corporate actions
Recent dividends, bonuses and splits
- 16 Feb 2026 · Interim Dividend - Rs. 10
- 19 Aug 2025 · Final Dividend - Rs. 10
- 14 Feb 2025 · Interim Dividend - Rs. 9
- 16 Aug 2024 · Final Dividend - Rs. 10
- 20 Feb 2024 · Interim Dividend - Rs. 6
- 18 Aug 2023 · Final Dividend - Rs. 9
Financials are as reported by the company (consolidated), in ₹ crore. Source: FinEdge exchange filings feed. Figures can differ from other sites because of one-off items and restatements. Callouts above are arithmetic on reported data, not recommendations.
Research data on this page is provided under Wright Research's SEBI Research Analyst registration. The Terms & Conditions of our Research Analyst services apply.